Guo, L., Zheng, J., Luo, J., Zhang, Z., & Shao, G. (2020). Targeting Yes1 Associated Transcriptional Regulator Inhibits Hepatocellular Carcinoma Progression and Improves Sensitivity to Sorafenib: An in vitro and in vivo Study. Onco Targets Ther.

Guo, Liwen, Jiaping Zheng, Jun Luo, Zhewei Zhang, and Guoliang Shao. "Targeting Yes1 Associated Transcriptional Regulator Inhibits Hepatocellular Carcinoma Progression and Improves Sensitivity to Sorafenib: An in Vitro and in Vivo Study." Onco Targets Ther 2020.

Guo, Liwen, et al. "Targeting Yes1 Associated Transcriptional Regulator Inhibits Hepatocellular Carcinoma Progression and Improves Sensitivity to Sorafenib: An in Vitro and in Vivo Study." Onco Targets Ther 2020.